Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference36 articles.
1. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy;Hogg;JAMA,1998
2. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic;Corbett;Arch Intern Med,2003
3. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach: 2010 Revision. Geneva: World Health Organization; 2010.
4. Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug–drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients;Manosuthi;Antimicrob Agents Chemother,2013
5. The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV–TB co-infected Indian patients receiving rifampicin based antituberculosis treatment;Sinha;AIDS Res Ther,2011
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sociobehavioral Risk Factors and Clinical Implications of Late Presentation Among People Living with HIV in the Brazilian Amazon Region;AIDS and Behavior;2024-07-11
2. HLA-B*13, B*35 and B*39 Alleles Are Closely Associated With the Lack of Response to ART in HIV Infection: A Cohort Study in a Population of Northern Brazil;Frontiers in Immunology;2022-03-16
3. Spousal intimacy, type of antiretroviral drug and antiretroviral therapy adherence among HIV patients in Bandung, Indonesia;Journal of Public Health Research;2021-05-31
4. Integrase inhibitors versus efavirenz combination antiretroviral therapies for TB/HIV coinfection: a meta-analysis of randomized controlled trials;AIDS Research and Therapy;2021-05-01
5. OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath;European Journal of Pharmacology;2020-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3